Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 408-210-8 | CAS number: 124605-82-9 C.I. DIRECT BLUE 301; DIRECT BLUE 301
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 02, 1990 - November 08, 1990
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline 473 study; GLP study. In all experiments cells were treated for 4 hours, no continuous treatment was performed.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene
- EC Number:
- 408-210-8
- EC Name:
- Tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene
- Cas Number:
- 124605-82-9
- Molecular formula:
- C33 H26 N8 O14 S4 .x Li .x Na
- IUPAC Name:
- dilithium(1+) disodium 5-amino-3-{2-[4-(2-{4-[2-(8-amino-1-hydroxy-3,6-disulfonatonaphthalen-2-yl)diazen-1-yl]-2-methylphenyl}diazen-1-yl)phenyl]diazen-1-yl}-4-hydroxynaphthalene-2,7-disulfonate
- Details on test material:
- - Physical state: dark blue solid
- Stability under test conditions: Pure: stable for 5 years. In solvent: stable for at least 48 hours in water, methanol, and acetone
- Storage condition of test material: room temperature
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM (minimal essential medium) supplemented with 10 % fetal calf serum (FCS).
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 liver microsomal fraction
- Test concentrations with justification for top dose:
- Experiment I:
without S9 mix:
7 h: 0.03; 0.1; 0.5; 1.0 mg/ml
18 h: 0.003; 0.01; 0.03; 0.1; 0.5; 1.0 mg/ml
28 h: 0.03; 0.1; 0.5; 1.0 mg/ml
with S9 mix:
7 h: 0.1; 0.5; 2.5; 5.0 mg/ml
18 h: 0.01; 0.03; 0.1; 0.5; 2.5; 5.0 mg/ml
28 h: 0.1; 0.5; 2.5; 5.0 mg/ml
Experiment II:
without S9 mix:
28 h: 0.03; 0.10; 0.25; 0.50; 0.80; 1.00 mg/ml
The following dose levels were evaluated:
without S9 mix:
7 h: 0.1 mg/ml
18 h: 0.01; 0.03; 0.1 mg/ml
28 h: 0.5 mg/ml
with S9 mix:
7 h: 0.1 mg/ml
18 h: 0.01; 0.03; 0.1 mg/ml
28 h: 0.1 mg/ml - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: dissolved in culture medium without fetal calf serum.
Controls
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- culture medium without fetal calf serum.
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: Without S9-mix: Ethylmethanesulfonate, With S9-mix: Cyclophosphamide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
Two days old logarithmically growing stock cultures more than 50 % confluent were trypsinised and a single cell suspension was prepared. The cells were seeded into Quadriperm dishes (Heraeus, D-6450 Hanau, GER) which contained microscopic slides. After 48 h (7 h , 28 h preparation interval) and 55 h (18 h preparation interval) the medium was replaced with serum-free medium containing the test article, either without S9 mix or with 20 µl/ml S9 mix. After 4 hours this medium was replaced with normal medium after rinsing twice with "saline G". 5, 15.5 and 25.5 h after the start of the treatment colcemid was added (0.2 µg/ml culture medium) to the cultures. 2.0 h (7 h interval) or 2.5 h later, (18 h and 28 h interval) the cells were treated on the slides in the chambers with hypotonic solution (0.4 % KCl) for 20 min at 37° C. After incubation in the hypotonic solution the cells were fixed with 3 + 1 absolute methanol + glacial acetic acid. All two slides per group were prepared. After fixation the cells were stained with giemsa.
SPINDLE INHIBITOR (cytogenetic assays): Colcemid
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 100 per slide
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: yes - Evaluation criteria:
- A test article is classified as mutagenic if it induces either a significant dose-related increase in the number of structural chromosomal aberrations or a significant positive response for at least one of the test points. A test article producing neither a significant dose-related increase in the number of structural chromosomal aberrations nor a significant positive response at any one of the test points is considered non-mutagenic in this system. This can be confirmed by means of the chi-square test. However, both biological and statistical significance should be considered together.
- Statistics:
- statistical significance at the five per cent level (p < 0.05) was evaluated by means of the chi-square test. Evaluation was performed only for cells carrying aberrations exclusive gaps.
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
In the pre-experiment on toxicity (colony forming ability) after treatment with concentrations higher than 0.05 (without S9 mix) and 0.001 mg/ml (with S9 mix) the colony forming ability was clearly reduced. In the test groups with S9 mix, the toxicity showed no dose dependency.
According to the results from this pre-experiment six concentrations (18 h interval) to be applied in the chromosomal aberration assay were chosen.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
The mitotic index was at least slightly reduced after treatment with the highest concentration at fixation intervals 7 h (with and without S9 mix), 18 h (with S9 mix) and 28 h (without S9 mix) . - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
In experiment I (28 h, without S9 mix), a relative high spontaneous aberration rate (4.5 %) were found with 2.0 % cells carrying exchanges (data not reported). To overcome possible incalculable effects, several experimental points (one control and 6 treatment groups) at this interval were repeated in an independent experiment. In this experiment a slight increase in the aberration rate was found as compared to the corresponding control. However, this increase was observed only in one of the two slides. In addition, the increase (5.5 %) was near to the control rate (3.5 %) and not statistically significant. Therefore, this effect was not regarded as biologically relevant. The positive controls showed distinct increases in cells with structural chromosome aberrations.
In conclusion, it can be stated that in the described study and under the experimental conditions reported, the test article did not induce structural chromosome aberrations in the V79 Chinese hamster cell line.
MUTAGENICITY DATA
Fixation Interval: 7 h | % aberrant cells | |||||
article | number of cells analyzed | concentration mg/ml | S9-Mix | incl. Gaps | excl. Gaps | exchanges |
solvent control | 200 | 0 | - | 8 | 1 | 0 |
test article | 200 | 0.1 | - | 3.5 | 1 | 0 |
solvent control | 200 | 0 | + | 6.5 | 3 | 0 |
test article | 200 | 0.1 | + | 7.5 | 3 | 1 |
Fixation Interval: 18 h | % aberrant cells | |||||
article | number of cells analyzed | concentration mg/ml | S9-Mix | incl. Gaps | excl. Gaps | exchanges |
solvent control | 200 | 0 | - | 6.5 | 2.5 | 0.5 |
positive control EMS | 200 | 0.72 | - | 11 | 11 | 6.5 |
test article | 200 | 0.01 | - | 4 | 1.5 | 0 |
test article | 200 | 0.03 | - | 6.5 | 3.5 | 1 |
test article | 200 | 0.1 | - | 3.5 | 2.5 | 0 |
solvent control | 200 | 0 | + | 5.5 | 1.5 | 0 |
positive control CPA | 200 | 0.0014 | + | 23 | 19 | 10 |
test article | 200 | 0.01 | + | 3 | 0 | 0 |
test article | 200 | 0.03 | + | 5 | 0.5 | 0 |
test article | 200 | 0.1 | + | 3.5 | 2 | 0.5 |
Fixation Interval: 28 h | % aberrant cells | |||||
article | number of cells analyzed | concentration mg/ml | S9-Mix | incl. Gaps | excl. Gaps | exchanges |
solvent control | 200 | 0 | - | 5 | 3.5 | 0.5 |
test article | 200 | 0.5 | - | 9 | 5.5 | 0.5 |
solvent control | 200 | 0 | + | 3 | 2 | 0.5 |
test article | 200 | 0.1 | + | 4 | 1.5 | 0.5 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Under the experimental conditions reported, the test article did not induce structural chromosome aberrations in the V79 Chinese hamster cell line. - Executive summary:
The test article was assessed for its potential to induce structural chromosome aberrations in V79 cells of the Chinese hamster in vitro in the absence and presence of metabolic activation by S9 mix. Preparation of chromosomes was done 7 h (high dose), 18 h (low, medium and high dose) and 28 h (high dose) after start of the treatment with the test article. The treatment interval was 4 h. In each experimental group two parallel cultures were used. Per culture 100 metaphases were scored for structural chromosome aberrations.
The following dose levels were evaluated:
Without S9 mix:
7 h: 0.10 mg/ml
18 h: 0.01; 0.03; 0.10 mg/ml
28 h; 0.50 mg/ml
with S9 mix:
7 h: 0.10 mg/ml
18 h: 0.01; 0.03; 0.10 mg/ml
28 h: 0.10 mg/ml
Both, in the absence and presence of S9 mix the test article did not increase biologically relevantly the frequency of cells with aberrations at any fixation interval. The aberration rates of the cells after treatment with the test article (0.0 % - 5.5 %) were in or near to the range of the control values; 1.0 % - 3.5 %. In experiment I (28 h, without S9 mix), a relative high spontaneous aberration rate (4.5 %) were found with 2.0 % cells carrying exchanges (data not reported). To overcome possible incalculable effects, several experimental points (one control and 6 treatment groups) at this interval were repeated in an independent experiment. In this experiment a slight increase in the aberration rate was found as compared to the corresponding control. However, this increase was observed only in one of the two slides. In addition, the increase (5.5 %) was near to the control rate (3.5 %) and not statistically significant. Therefore, this effect was not regarded as biologically relevant. No relevant deviation from the control data was found after treatment with the test article regarding polyploid metaphases. EMS (0.72 mg/ml) and CPA (1.40 µg/ml) were used as positive controls and showed distinct increases in cells with structural chromosome aberrations. In conclusion, it can be stated that in the described study and under the experimental conditions reported, the test article did not induce structural chromosome aberrations in the V7 9 Chinese hamster cell line.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
